HANXBIO-B Announces Conclusion of Stabilization Period, No Stabilization Actions Taken, and Over-Allotment Option Lapses

Deep News01-26

HANXBIO-B (03378) has issued an announcement stating that the stabilization period relating to the global offering concluded on Saturday, January 17, 2026, which was the 30th day after the deadline for submitting Hong Kong public offering applications. Furthermore, the sponsor and overall coordinator (for itself and on behalf of the international underwriters) confirmed that there was no over-allocation of the offer shares under the international offering. Consequently, the over-allotment option was not exercised and lapsed on Saturday, January 17, 2026. The stabilization agent informed the company that neither the stabilization agent nor any person acting on its behalf undertook any stabilization actions during the stabilization period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment